loading

Cadrenal Therapeutics Inc Azioni (CVKD) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
4.93%
3.7343
3.928 2.46 2.4666 1.7556
Operating Income/Loss
4.93%
-3.7343
-3.928 -2.46 -2.4666 -1.7556
Nonoperating Income/Loss
18.88%
0.067
0.0826 0.0521 0.0736 0.0923
Income/Loss From Continuing Operations Before Tax
4.63%
-3.6673
-3.8454 -2.4078 -2.393 -1.6633
Income/Loss From Continuing Operations After Tax
4.63%
-3.6673
-3.8454 -2.4078 -2.393 -1.6633
Net Income/Loss
4.63%
-3.6673
-3.8454 -2.4078 -2.393 -1.6633
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
6.38%
1.9616
1.8441 1.104 16.01 16.01
Diluted Average Shares
6.38%
1.9616
1.8441 1.104 16.01 16.01
Basic Earnings Per Share
10.53%
-1.87
-2.09 -2.18 -0.15 -0.10
Diluted Earnings Per Share
10.53%
-1.87
-2.09 -2.18 -0.15 -0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$26.62
price down icon 0.36%
$45.59
price up icon 1.77%
$101.46
price up icon 0.66%
$106.91
price up icon 1.17%
$151.10
price up icon 2.96%
biotechnology ONC
$349.40
price up icon 0.86%
Capitalizzazione:     |  Volume (24 ore):